These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32154163)

  • 1. L-Ascorbic Acid and α-Tocopherol Synergistically Triggers Apoptosis Inducing Antileukemic Effects of Arsenic Trioxide
    Vineetha RC; Hariharan S; Jaleel A; Chandran M; Nair RH
    Front Oncol; 2020; 10():65. PubMed ID: 32154163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-ascorbic acid and α-tocopherol attenuate arsenic trioxide-induced toxicity in H9c2 cardiomyocytes by the activation of Nrf2 and Bcl2 transcription factors.
    Vineetha RC; Binu P; Arathi P; Nair RH
    Toxicol Mech Methods; 2018 Jun; 28(5):353-360. PubMed ID: 29297235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Ascorbic Acid and α-Tocopherol Reduces Hepatotoxicity Associated with Arsenic Trioxide Chemotherapy by Modulating Nrf2 and Bcl2 Transcription Factors in Chang liver Cells.
    Vineetha RC; Archana V; Binu P; Arathi P; Nair RH
    Nutr Cancer; 2018; 70(4):684-696. PubMed ID: 29697268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Biol Trace Elem Res; 2015 Feb; 163(1-2):112-23. PubMed ID: 25431299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
    Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
    J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the Nrf2 Signaling Pathway Involving KLF9 Plays a Critical Role in Allicin Resisting Against Arsenic Trioxide-Induced Hepatotoxicity in Rats.
    Yang D; Lv Z; Zhang H; Liu B; Jiang H; Tan X; Lu J; Baiyun R; Zhang Z
    Biol Trace Elem Res; 2017 Mar; 176(1):192-200. PubMed ID: 27561292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies.
    Chen Z; Chen GQ; Shen ZX; Chen SJ; Wang ZY
    Semin Hematol; 2001 Jan; 38(1):26-36. PubMed ID: 11172537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
    Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
    Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
    Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
    Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different administration patterns of docosahexaenoic acid in combating cytotoxic manifestations due to arsenic trioxide (acute promyelocytic leukemia drug) induced redox imbalance in hepatocytes.
    Abhilash S; Siviyasankar R; Binu P; Arathi P; Harikumaran Nair R
    Prostaglandins Other Lipid Mediat; 2018 May; 136():64-75. PubMed ID: 29751151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia drug - arsenic trioxide in the presence of eugenol shows differential action on leukemia cells (HL-60) and cardiomyocytes (H9c2) - inference from NMR study.
    Binu P; Soman R; Zakhariah Hisham O; Narayanan SP; Nair RH
    Toxicol Mech Methods; 2021 Jul; 31(6):457-466. PubMed ID: 33879037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic Trioxide Induces Apoptosis of HL-60 Cells via Activation of Intrinsic Caspase Protease with Mitochondrial Dysfunction.
    Jung BH; Park C; Kim HR; Park MR
    Cancer Res Treat; 2002 Aug; 34(4):308-15. PubMed ID: 26680881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
    Shao W; Fanelli M; Ferrara FF; Riccioni R; Rosenauer A; Davison K; Lamph WW; Waxman S; Pelicci PG; Lo Coco F; Avvisati G; Testa U; Peschle C; Gambacorti-Passerini C; Nervi C; Miller WH
    J Natl Cancer Inst; 1998 Jan; 90(2):124-33. PubMed ID: 9450572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
    Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R
    Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
    Huan SY; Yang CH; Chen YC
    Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity.
    Diaz Z; Laurenzana A; Mann KK; Bismar TA; Schipper HM; Miller WH
    Leukemia; 2007 Oct; 21(10):2117-27. PubMed ID: 17690699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?
    Bachleitner-Hofmann T; Gisslinger B; Grumbeck E; Gisslinger H
    Br J Haematol; 2001 Mar; 112(3):783-6. PubMed ID: 11260084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mechanisms of arsenic trioxide-induced apoptosis in hematopoietic malignant cells].
    Cai X; Chen G; Jia P
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):452-5. PubMed ID: 11715442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.